These benchmarks are derived from the STEP clinical trial data and adjusted for real-world conditions where adherence and lifestyle factors vary more than in controlled studies
Its tough to be consistent, and its tough to get a consistent medication repeatedly based on access and availability. That start-stop pattern matters because blood sugar, blood pressure and other metabolic markers can swing up and down, too
MIM received honoraria for speaking at meetings from AstraZeneca, Novo Nordisk, Bruno Farmaceutici, Mundipharma, and Sanofi
Were not just thorough reporters we sift through mountains of information, test and compare products, and consult experts on any topics we arent already schooled specialists in to deliver useful, realistic product recommendations based on our extensive and hands-on analysis
The key is to keep changes simple and doable, so they stick
A five-month treatment with PEGylated exenatide (NLY01) was found to decrease the secretion of complement 1q (C1q), IL-1, and TNF- by primary mouse microglia, thereby limiting the conversion of astrocytes to a neurotoxic phenotype
.webp)
